Trending

Pharma regulation

EC to update IP rules to benefit generic exports

EC to update IP rules to benefit generic exports

The European Commission (EC) is proposing to adjust intellectual property (IP) rules to help Europe’s pharma companies tap into fast-growing global markets.

X

EC to update IP rules to benefit generic exports

https://pharmaphorum.com/news/ec-update-ip-rules-generic-exports/

Submitting risk management plans on the new EU template: 3 tips

Submitting risk management plans on the new EU template: 3 tips

Are you prepared for the upcoming changeover to the new EU risk management plan (RMP) template? Seema Jaitly offers some timely guidance on the new EU RMP document.

X

Submitting risk management plans on the new EU template: 3 tips

https://pharmaphorum.com/views-and-analysis/submitting-risk-management-plans-new-eu-template-3-tips/

Amsterdam will minimise disruption – but no EMA guarantee on approvals

Amsterdam will minimise disruption – but no EMA guarantee on approvals

Amsterdam chosen as the new home of the European Medicines Agency.

X

Amsterdam will minimise disruption – but no EMA guarantee on approvals

https://pharmaphorum.com/news/amsterdam-will-minimise-ema-disruption-no-guarantees-approvals/

Still room to cut FDA red tape, says Novartis chief

Still room to cut FDA red tape, says Novartis chief

Joseph Gulfo the latest name to be put forward for FDA Commissioner

X

Still room to cut FDA red tape, says Novartis chief

https://pharmaphorum.com/news/still-room-cut-fda-red-tape-says-novartis-chief/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com